www.fdanews.com/articles/160004-glaxo-sells-bad-with-good-in-safety-push-amid-china-woes

Glaxo Sells Bad With Good in Safety Push Amid China Woes

November 7, 2013

GlaxoSmithKline is intent on selling its new lung drug, Breo, amid a massive bribery scandal still playing out in China.
Bloomberg